BCAT-IN-2（Cat No.:I045252）is a selective inhibitor of branched-chain aminotransferase (BCAT), an enzyme that catalyzes the reversible transamination of branched-chain amino acids (BCAAs) to their corresponding keto acids. By blocking BCAT activity, BCAT-IN-2 disrupts BCAA metabolism, affecting cellular energy production, signaling pathways, and nitrogen balance. This compound is valuable for studying metabolic reprogramming in cancer, neurological disorders, and metabolic diseases where altered BCAA metabolism plays a role. Its potency, selectivity, and suitability for cell-based and biochemical assays make BCAT-IN-2 an important research tool for exploring amino acid–dependent physiological and pathological processes.